Recent Posts

• The Gut Microbiome May Unlock New Treatment Paradigms For Neurological Diseases – Axial Therapeutics
• Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism
• Behavioral Signals Recognized As Emotion AI Leader By Gartner In Multiple 2023 Hype Cycle Reports
• MemVerge and SK hynix Accelerate Memory Pooling and Sharing Software Development with CXL Flight Simulator
• Actuate Therapeutics Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Pancreatic Cancer